In aggressive breast cancer, RAC3’s specific binding partner CIB1 facilitates the recruitment of RAC3, promoting integrin activation at invasive pseudopodia, thereby regulating adhesion and degradation of the extracellular matrix (ECM) (Wang et al., 2022). Here, CIB1 is linked to breast carcinoma.